Rafael Holdings, Inc. (RFL) stock
RFLNYSEPharmaceutical PreparationsFiscal year ends July 31
$0.90−0.09 (-8.82%)
Close on Nov 19, 2026Market cap $46.97MP/E –Yield –
Rafael shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Rafael's shares outstanding was 52M at Jul 31, 2026. For fiscal 2026 it was 51M, up 74.7% from the year before. Over ten years it grew 129.9% a year on average. The highest annual figure on record is 51M in fiscal 2026.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jul 31, 2026 | 51M | +74.7% |
| FY2025 | Jul 31, 2025 | 29M | +23.9% |
| FY2024 | Jul 31, 2024 | 24M | +2.1% |
| FY2023 | Jul 31, 2023 | 23M | +17.7% |
| FY2022 | Jul 31, 2022 | 20M | +19.6% |
| FY2021 | Jul 31, 2021 | 17M | +4.8% |
| FY2020 | Jul 31, 2020 | 16M | +18.8% |
| FY2019 | Jul 31, 2019 | 13M | +6.3% |
| FY2018 | Jul 31, 2018 | 12M | +99900.0% |
| FY2017 | Jul 31, 2017 | 0M | 0.0% |
| FY2016 | Jul 31, 2016 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jul 31, 2026 | 52M | +22.0% |
| Q3 FY2026CQ1 2026 | Apr 30, 2026 | 51M | +103.0% |
| Q2 FY2026CQ4 2025 | Jan 31, 2026 | 51M | +112.1% |
| Q1 FY2026CQ3 2025 | Oct 31, 2025 | 51M | +112.7% |
| Q4 FY2025CQ2 2025 | Jul 31, 2025 | 42M | +76.8% |
| Q3 FY2025CQ1 2025 | Apr 30, 2025 | 25M | +6.1% |
| Q2 FY2025CQ4 2024 | Jan 31, 2025 | 24M | -1.0% |
| Q1 FY2025CQ3 2024 | Oct 31, 2024 | 24M | +1.8% |
| Q4 FY2024CQ2 2024 | Jul 31, 2024 | 24M | +1.7% |
| Q3 FY2024CQ1 2024 | Apr 30, 2024 | 24M | +1.7% |
| Q2 FY2024CQ4 2023 | Jan 31, 2024 | 24M | +5.4% |
| Q1 FY2024CQ3 2023 | Oct 31, 2023 | 24M | +2.7% |
| Q4 FY2023CQ2 2023 | Jul 31, 2023 | 24M | +13.9% |
| Q3 FY2023CQ1 2023 | Apr 30, 2023 | 23M | +18.3% |
| Q2 FY2023CQ4 2022 | Jan 31, 2023 | 23M | +17.5% |
| Q1 FY2023CQ3 2022 | Oct 31, 2022 | 23M | +21.5% |
| Q4 FY2022CQ2 2022 | Jul 31, 2022 | 21M | +18.4% |
| Q3 FY2022CQ1 2022 | Apr 30, 2022 | 20M | +18.5% |
| Q2 FY2022CQ4 2021 | Jan 31, 2022 | 20M | +21.9% |
| Q1 FY2022CQ3 2021 | Oct 31, 2021 | 19M | +19.8% |
| Q4 FY2021CQ2 2021 | Jul 31, 2021 | 17M | +10.3% |
| Q3 FY2021CQ1 2021 | Apr 30, 2021 | 17M | +5.4% |
| Q2 FY2021CQ4 2020 | Jan 31, 2021 | 16M | +2.4% |
| Q1 FY2021CQ3 2020 | Oct 31, 2020 | 16M | +1.2% |
| Q4 FY2020CQ2 2020 | Jul 31, 2020 | 16M | +13.5% |
| Q3 FY2020CQ1 2020 | Apr 30, 2020 | 16M | +13.6% |
| Q2 FY2020CQ4 2019 | Jan 31, 2020 | 16M | +17.1% |
| Q1 FY2020CQ3 2019 | Oct 31, 2019 | 16M | +24.5% |
| Q4 FY2019CQ2 2019 | Jul 31, 2019 | 14M | +13.2% |
| Q3 FY2019CQ1 2019 | Apr 30, 2019 | 14M | +11.0% |
| Q2 FY2019CQ4 2018 | Jan 31, 2019 | 13M | +7.6% |
| Q1 FY2019CQ3 2018 | Oct 31, 2018 | 13M | +0.2% |
| Q4 FY2018CQ2 2018 | Jul 31, 2018 | 12M | -1.8% |
| Q3 FY2018CQ1 2018 | Apr 30, 2018 | 13M | – |
| Q2 FY2018CQ4 2017 | Jan 31, 2018 | 13M | – |
| Q1 FY2018CQ3 2017 | Oct 31, 2017 | 13M | – |
| Q3 FY2017CQ1 2017 | Apr 30, 2017 | 13M | – |
See a number that looks wrong?